Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin

Clinical trial NCT01225562 · COMPLETED

Trial details

NCT number: NCT01225562
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Myocardial Infarction Cardiovascular Death Atherothrombosis Stroke

Start date: 2010-10-01
Primary completion: 2014-12-01
Enrollment: 21379

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.